LAURA ANN KRAGIE, M.D.
Osteopathic Medicine at Wisconsin Ave, Bethesda, MD

License number
Maryland 78907
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
5480 Wisconsin Ave #1201, Bethesda, MD 20815
Phone
(301) 907-6605

Professional information

See more information about LAURA ANN KRAGIE at trustoria.com
Laura Ann Kragie Photo 1
Dr. Laura Ann Kragie, Chevy Chase MD - MD (Doctor of Medicine)

Dr. Laura Ann Kragie, Chevy Chase MD - MD (Doctor of Medicine)

Specialties:
Clinical Pharmacology
Address:
5480 Wisconsin Ave SUITE 1201, Chevy Chase 20815
(301) 907-6605 (Phone)
Languages:
English
Education:
Medical School
University of Ia Roy J & L Carver Com
Graduated: 1983


Laura Kragie Photo 2
Method Of Treating Vitamin B12 Deficiency

Method Of Treating Vitamin B12 Deficiency

US Patent:
2010001, Jan 21, 2010
Filed:
Oct 31, 2008
Appl. No.:
12/262677
Inventors:
Cristina Castelli - New York NY, US
Laura Kragie - Chevy Chase MD, US
Assignee:
Emisphere Technologies Inc. - Cedar Knolls NJ
International Classification:
A61K 31/714, A61P 43/00
US Classification:
514 52
Abstract:
A novel method and composition for treating vitamin Bdeficiency mammals that fail to respond to oral vitamin Btherapy.


Laura Kragie Photo 3
Method Of Treating Vitamin Bdeficiency

Method Of Treating Vitamin Bdeficiency

US Patent:
8288360, Oct 16, 2012
Filed:
Aug 9, 2011
Appl. No.:
13/206090
Inventors:
Cristina Castelli - Cedar Knolls NJ, US
Laura Kragie - Chevy Chase MD, US
Assignee:
Emisphere Technologies, Inc. - Cedar Knolls NJ
International Classification:
A61K 31/70
US Classification:
514 52
Abstract:
A novel method and composition for treating vitamin Bdeficiency mammals that fail to respond to oral vitamin Btherapy.


Laura Kragie Photo 4
Method Of Treating Vitamin Bdeficiency

Method Of Treating Vitamin Bdeficiency

US Patent:
8557792, Oct 15, 2013
Filed:
Sep 14, 2012
Appl. No.:
13/618654
Inventors:
Cristina Castelli - New York NY, US
Laura Kragie - Chevy Chase MD, US
Assignee:
Emisphere Technologies, Inc. - Roseland NJ
International Classification:
A61K 31/70
US Classification:
514 52
Abstract:
A novel method and composition for treating vitamin Bdeficiency mammals that fail to respond to oral vitamin Btherapy.